Feed Preview

Fast Growing

Genetic Engineering to Program Cells

Genetic Engineering to Program Cells diagram by StudioMolekuul, Shutterstock
StudioMolekuul, Shutterstock

Genetic engineering is a process that alters the genetic structure of an organism by removing or introducing DNA. This technique is being tested to program cells. Discover the latest research on genetic engineering to program cells here.

Top 20 most recent papers
May 23, 2020
Review

Reprogramming of serine, glycine and one-carbon metabolism in cancer

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Albert M Li, Jiangbin Ye
May 24, 2020
Review

Macrophage targeting in cancer

Annals of the New York Academy of Sciences
Martha Lopez-YrigoyenJeffrey W Pollard
May 21, 2020

METTL1 limits differentiation and functioning of EPCs derived from human-induced pluripotent stem cells through a MAPK/ERK pathway

Biochemical and Biophysical Research Communications
Yujie DengBeixin Yu
May 26, 2020

Role of dendritic cell metabolic reprogramming in tumor immune evasion

International Immunology
Michael P PlebanekBrent A Hanks
May 23, 2020

Raptor determines β-cell identity and plasticity independent of hyperglycemia in mice

Nature Communications
Qinglei YinGuang Ning
May 23, 2020
ReviewOpen Access

Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer

Advanced Science
Ahmed M E AbdallaGuang Yang
May 26, 2020
Preprint

A Consensus Transcriptional Landscape of Human End-Stage Heart Failure

medRxiv
R. O. Ramirez FloresJulio Saez-Rodriguez
May 23, 2020

Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression

Molecular Cancer Research : MCR
Camille SullivanSusan E Waltz
May 22, 2020
Review

Plant cell totipotency: Insights into cellular reprogramming

Journal of Integrative Plant Biology
Ying Hua SuXian Sheng Zhang

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

© 2020 Meta ULC. All rights reserved
/feed-previews/genetic-engineering-to-program/f884d981-f108-49ca-8605-a4a2843df4d6